24th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems

About Conference

After a successful conference of Pharmaceutical 2022, Pharma Conferences team cordially invites participants from all over the world to attend "24^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems" (Pharmaceutica 2023) slated on January 30-31, 2023, Barcelona, Spain. This Pharmaceutics Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.

Novel drug delivery systems Conference is one of the well-established conference among Pharmaceutical Conferences organized by Conference Series llc Ltd

Pharmaceutical 2023 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics & Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical Research, Pharmacogenetics and Genomics, Regulatory Affairs and Intellectual Property Rights, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education and Practice

2023 Highlights:

200+ Participation (70% Industry: 30% Academia)
9+ Keynote Speakers
30+ Plenary Speakers
3+ Exhibitors
14 Innovative Educational Sessions
B2B Meetings

Conference Highlights

Track 1: Bio-Pharmaceutics

Bio Pharmaceutics conferences plays an important role in drug discovery like drug disposition, Innovations in clinical development, Pharmaceutical technology, Pharmaceutics and drug delivery, Drug design, Targeted drug, gene delivery, Sustained drug delivery system, Routes of administration, Fundamental drug development.

For more information visit: Pharmaceutical Conferences

Related Conferences:

30^th International Conference on World Nursing Education, October 17-18, 2022 Barcelona, Spain; 14th International Conference On Biosimilars And Pharma Innovations, August 22-23, 2022 Webinar; 3rd International Conference On Biomedicine & Pharmacotherapy, August 24-25, 2022 Toronto, Canada; 38th World Pharmacology And Therapeutics Forum, November 21-22, 2022 ROME, ITALY; 15th International Conference And Exhibition On Pharmacovigilance & Drug Safety, September 26-27, 2022 PARIS, FRANCE

Related Societies:

Bio Pharma Societies in USA: International Biopharmaceutical Association, Consumer Healthcare Products Association (CHPA), Generic Pharmaceutical Association (GPhA), International Pharmaceutical Expedient Council, Pharmaceutical Research and Manufacturers of America (PhRMA) Synthetic Organic Chemical Manufacturers Association (SOCMA), Biotech Industry Association (BIO), Parenteral Drug Association (PDA), Chinese Biopharmaceutical Association, Pharma & Biopharma Outsourcing Association (PBOA), SAFE-BioPharma Association and The BioPharmaceutical Emerging Best Practices Association (BEBPA)

Bio Pharma Societies in Europe: European Federation of Pharmaceutical Industries and Associations (EFPIA), European Biopharmaceutical Enterprises (EBE), European Association of Pharma Biotechnology, International Federation of Pharmaceutical Manufacturers & Associations, European Federation of Biotechnology, EuropaBio and European and Developing Countries Clinical Trials Partnership

Bio Pharma Societies in Asia: The Hong Kong Association of the Pharmaceutical Industry, International Pharmaceutical Manufacturers Group, International Research-based Pharmaceutical Manufacturers Association, Japan Pharmaceutical Manufacturers Association, Korea Pharmaceutical and Bio-Pharma Manufacturers Association, Korean Research-based Pharmaceutical Industry Association, Organization of Pharmaceutical Producers of India, Pharmaceutical Association of Malaysia, Pharmaceutical and Healthcare Association of the Philippines, China Pharmaceutical Innovation & Research Development Association, Pharmaceutical Research & Manufacturers Association, R&D-based Pharmaceutical Association Committee, Singapore Association of Pharmaceutical Industries

Bio Pharmaceutics Journals: European Journal of Pharmaceutics and Biopharmaceutics, International Journal of Biopharmaceutics, Journal of Biopharmaceutics and Biotechnology, Biopharmaceutics and Drug Disposition, Journal of Pharmacokinetics and Biopharmaceutics, Journal of Biopharmaceutical Statistics, Journal of Biopharmaceutics and Therapeutic Challenges, Journal of applied biopharmaceutics and pharmacokinetics, Journal of Applied Biopharmaceutics and Pharmacokinetics, Statistics in Biopharmaceutical Research, EBR - European Biopharmaceutical Review, Russian Journal of Biopharmaceuticals

Track 2: Pharmaceutical Chemistry

Pharmaceutical Chemistry is the study of drug design to optimize pharmacokinetics and pharmacodynamics, and synthesis of new drug molecules (Medicinal Chemistry 2022). Pharmaceutical Chemistry is a branch of chemistry that deals with the chemical, biochemical and pharmacological aspects of drugs. It includes synthesis/isolation, identification, structural elucidation, structural modification, structural activity relationship (SAR) studies, study of the chemical characteristics, biochemical changes after drug administration and their pharmacological effects as well as analysis of drugs. In more simple words it is more broader than medicinal chemistry in its application also in the fields of analysis, identification, as well as, structural elucidation of drugs

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:https://novel-drugdelivery-systems.pharmaceuticalconferences.com/

Pharmaceutical Chemistry Societies in USA: American Chemical Society, American Association of Pharmaceutical Scientists, Medicinal Chemistry Society, American Chemistry Council (ACC), International Council of Chemical Associations, Chemical Institute of Canada (CIC) and World Association of Theoretical and Computational Chemists (WATOC)

Pharmaceutical Chemistry Societies in Europe: EuCheMS (European Association for Chemical and Molecular Sciences), Chemical Industries Association, European Federation for Medicinal Chemistry (EFMC), Swiss Chemical Society (SCS), Turkish Association of Medicinal and Pharmaceutical Chemistry, Royal Society of Chemistry (RSC), Slovenian Pharmaceutical Society, Polish Society of Medicinal Chemistry, Hungarian Chemical Society (HCS), The French Medicinal Chemistry Society (SCT) and Turkish Chemical Society (TCS)

Pharmaceutical Chemistry Societies in Asia and Pacific: The Chemical Society of Japan, Swiss Chemical Society, The Israel Chemical Society, Indian Society of Chemists and Biologists, The Royal Australian Chemical Institute, Federation of Asian Chemical Societies (FACS), Chinese Chemical Society, Korean Chemical Society, Singapore National Institute of Chemistry and Chemical Research Society of India

Pharmaceutical Chemistry Journals: Pharmaceutical Chemistry Journal, Chemical Sciences Journal, International Journal of Pharmaceutical Chemistry, Journal of the American Chemical Society, International Journal of Medicinal Chemistry, International Journal of Pharmaceutical Chemistry and Analysis, Journal of Pharmaceutical Chemistry, European Journal of Medicinal Chemistry and Journal of Pharmaceutical Chemistry & Chemical Science

Track 3: Drug Targeting and Design

Drug Design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques. This type of modeling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design. In addition to small molecules, biopharmaceuticals and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of this protein-based therapeutics have also been developed

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Drug Discovery Societies in USA: American Association of Pharmaceutical Scientists (AAPS), American Peptide Society (APS), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Pharmacology and Experimental Therapeutics (ASPET), Biophysical Society, American Association for Clinical Chemistry (AACC), American Crystallographic Association (ACA), American Institute of Chemical Engineers (AIChE)

Drug Discovery Societies in Europe: Royal Society of Biology, Association of the British Pharmaceutical Industry (ABPI), The BioIndustry Association, British Pharmacological Society (BPS), Biochemical Society, The Physiological Society, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), European Photochemistry Association, European Federation for Medicinal Chemistry (EFMC), European Federation for Pharmaceutical Sciences (EUFEPS), European Federation for the Science and Technology of Lipids (EuroFedLipid), Euroscience and International Pharmaceutical Federation

Drug Discovery Societies in Asia and Pacific: Chemical Society of Thailand, Singapore National Institute of Chemistry, Serbian Chemical Society (SCS), Integrated Chemists of the Philippines, New Zealand Institute of Chemistry, Malaysian Institute of Chemistry, Association of Latvian Chemical and Pharmaceutical Industry (LAKIFA), Kuwait Chemical Society

Drug Discovery Journals: American Journal of Drug Discovery and Development, Nature Reviews Drug Discovery, Drug Discovery Today, Expert Opinion on Drug Discovery, Current Pharmaceutical Design, Current Drug Discovery Technologies, International Journal of Drug Discovery, Drug Metabolism and Pharmacokinetics, International Journal of Drug Development and Research (IJDDR) and Drug Development Research, Journal of Computer-Aided Molecular Design, Drug Design, Development and Therapy, Journal of Drug Discovery, Development and Delivery, The Open Drug Discovery Journal and Drug Development and Industrial Pharmacy

Track 4: Pharmacokinetics and Pharmacodynamics in Drugs

Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient. Primary goals of clinical pharmacokinetics include enhancing efficacy and decreasing toxicity of a patient’s drug therapy. The development of strong correlations between drug concentrations and their pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to actual patient situations.

Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, including the time course and intensity of therapeutic and adverse effects. The effect of a drug present at the site of action is determined by that drug’s binding with a receptor.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Pharmacokinetics Societies in USA: AACP (American Association of Colleges in Pharmacy), American Association of Pharmaceutical Scientists-AAPS, American College of Clinical Pharmacy (ACCP), ACPE – Accreditation Council for Pharmacy Education, AMCP (Academy of Managed Care Pharmacy), American Pharmacists Association (APhA), American Society of Consultant Pharmacists -ASCP, ASHP – American Society of Health-System Pharmacists, AZO (Alpha Zeta Omega), BPS (Board of Pharmacy Specialties), CPA – Connecticut Pharmacists Association

Pharmacokinetics Societies in Europe: European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU), Danish Association of Pharmaconomists, Pharmaceutical Society of Ireland, National Pharmacy Association, Pharmaceutical Society of Northern Ireland and Royal Pharmaceutical Society (RPS), International Pharmaceutical Federation (FIP) and International Pharmaceutical Students' Federation (IPSF)

Pharmacokinetics Societies in Asia and Middle East: Australian College of Pharmacy, Pharmaceutical Society of Australia, The Pharmacy Guild of Australia, The Society of Hospital Pharmacists of Australia, Chinese Pharmaceutical Association, The Pharmaceutical Association of Israel and Kuwait Pharmaceutical Association

Pharmacokinetics & Pharmacodynamics Journals: Drug Metabolism and Pharmacokinetics, Journal of Pharmacokinetics and Pharmacodynamics, Journal of Pharmacokinetics & Experimental Therapeutics, Clinical Pharmacokinetics and International Journal of Pharmacokinetics

Track 5: Pharmaceutical Formulation

Pharmaceutics is the study of relationships between preformulation, pharmaceutical formulation, delivery, disposition and clinical response. The inherent instability nature of a new drug will alter its desired form into undesired form when presented in a suitable dosage form with the excipient/s upon storage. In early days this process was confined only for assessing few characteristics, but today this process is being considered as a formulation strategy and hence tremendous technological advancement has been achieved in this field which enables us to save time and money through planned management system and hence impacts Pharmaceutica 2022 to be a formulation conference. Use of glorious statistical software even based on artificial neural networking are made the task of preformulation and optimization process easier. Role of preformulation studies techniques like freeze drying aspects projects the event Pharmaceutics 2022 to pose as a freeze drying meeting in drug discovery, drug development plays major role in pharmaceutical formulation development and the studies will help in different dosage forms design. With the increasing number of novel and specialized compounds being developed, a "one size fits all" approach to drug formulation and delivery is no longer optimal, necessitating the consideration of formulations unique to each drug. NDDS conference will discuss on Early Approaches, Present Scenario and Future Prospects of Preformulation events. There are more than 1400 sustained or controlled release drugs have been approved all over the world. Pharmaceutical conferences discuss the state-of-art technology being applied and involve advances in formulation studies.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Pharmaceutical Formulations Societies in USA: International Society for Pharmaceutical Engineering, Consumer Healthcare Products Association (CHPA), Drug Information Association (DIA), Generic Pharmaceutical Association (GPhA), Pharmaceutical Research and Manufacturers of America (PhRMA), American Association of Pharmaceutical Scientists, American Pharmacists Association, American Society of Health Systems Pharmacists, National Association of Boards of Pharmacy, National Community Pharmacists Association, National Association of Chain Drug Stores (NACDS) and Pharmaceutical Care Management Association (PCMA)

Pharmaceutical Formulations Societies in Europe: International Federation of Pharmaceutical Manufacturers & Associations IFPMA, Association of the British Pharmaceutical Industry, European Federation of Pharmaceutical Industries and Associations (EFPIA)

Pharmaceutical Formulations Societies in Asia and Middle East: Pharmaceutical Society of Australia, The Japan Pharmaceutical Manufacturers Association (JPMA)

Pharmaceutical Formulations Journals: International Journal of Pharmaceutical Formulation and Analysis, International Journal of Drug Formulation and Research, International Journal of Drug Formulation & Research, Journal of Pharmaceutical Sciences, Pharmaceutical Development and Technology, International Journal of Pharmaceutical Formulation and Analysis, Pharmaceutical Research, Journal of Formulation Science & Bioavailability and International Journal of Pharmaceutics

Track 6: Pharmaceutical Manufacturing

Drug manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Pharmaceutical Manufacturing Societies in USA: Pharmaceutical Research and Manufacturers of America, Generic Pharmaceutical Association (GPhA), US Food and Drug Administration, The Latin American Federation of Pharmaceutical Industry, Consumer Healthcare Products Association (CHPA) and Drug Information Association (DIA)

Pharmaceutical Manufacturing Societies in Europe: Association of the British Pharmaceutical Industry (ABPI), The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Association of Research-Based Pharmaceutical Companies (AIFD), European Federation of Pharmaceutical Industries and Associations (EFPIA), EuropaBio, European Biological Enterprises (EBE), Association of International Pharm Manufacturers (AIPM),

Pharmaceutical Manufacturing Societies in Asia and Pacific: The Hong Kong Association of the Pharmaceutical Industry, Organization of Pharmaceutical Producers of India (OPPI), China Pharmaceutical Industry Association (CPIA), Chinese Pharmaceutical Association, R&D-based Pharmaceutical Association Committee (RDPAC), Pharmaceutical Association of Malaysia, European Federation of Pharmaceutical Industries and Associations (EFPIA), Singapore Association of Pharmaceutical Industries, Innovative Pharmaceutical Association South Africa (IPASA), South African Association of Pharmacists in Industry (SAAPI), Korean Research-Based Pharmaceutical Industry Association (KRPIA) International Research-Based Pharmaceutical Manufacturers Association (IRPMA), Pharmaceutical Research and Manufacturers Association (PreMA)

Pharmaceutical Manufacturing Journals: Journal of Pharmaceutical Innovation, Journal of Pharmaceutical Sciences, Pharma Manufacturing, The Pharmaceutical Journal, World Pharma Today and European Pharmaceutical Manufacturer

Track 7: Pharmaceutical Nanotechnology

Size reduction is a fundamental unit operation having important applications in pharmacy. It helps in improving solubility and bioavailability, reducing toxicity, enhancing release and providing better formulation opportunities for drugs. In most of the cases, size reduction is limited to micron size range, for example, various pharmaceutical dosage forms like powder, emulsion, suspension etc. Drugs in the nanometer size range enhance performance in a variety of dosage forms. Major advantages of nanosizing include (i) increased surface area, (ii) enhanced solubility, (iii) increased rate of dissolution, (iv) increased oral bioavailability, (v) more rapid onset of therapeutic action, (vi) less amount of dose required, (vii) decreased fed/fasted variability, and (viii) decreased patient-to-patient variability.

Pharmaceutical nanotechnology has provided more fine-tuned diagnosis and focused treatment of disease at a molecular level. Pharmaceutical nanotechnology is most innovative and highly specialized field, which will revolutionize the pharmaceutical industry in near future. Pharmaceutical nanotechnology presents revolutionary opportunities to fight against many diseases. It helps in detecting the antigen associated with diseases such as cancer, diabetes mellitus, neurodegenerative diseases, as well as detecting the microorganisms and viruses associated with infections. It is expected that in next 10 years market will be flooded with nanotechnology devised medicine.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Pharmaceutical Nanotechnology Societies in USA: International Association of Nanotechnology (IANT), American Bar Association Section Nanotechnology Project, American Chemical Society, American National Standards Institute Nanotechnology Panel, The American Society for Precision Engineering (ASPE), Converging Technologies Bar Association, National Institute for Nanotechnology, National Nanotechnology Initiative, International Institute for Nanotechnology

Pharmaceutical Nanotechnology Societies in Europe: European Nanoscience and Nanotechnology Association (ENNA), Erwin Schrödinger Society for Nanosciences (Austria), Nanotechnology Industries Association, British Society for Nanomedicine, Czech Nanotechnology Industries Association, European NanoBusiness Association (ENA), European Society for Precision Engineering and Nanotechnology, Russian Nanotechnology Corporation and Swiss Nanoscience Institute

Pharmaceutical Nanotechnology Societies in Asia and Pacific: Asian Nanoscience and Nanotechnology Association, National Center for Nanoscience and Technology, Iran Nanotechnology Initiative Council (INIC), Sri Lanka Institute of Nanotechnology and Nano Technology Research Association

Pharmaceutical Nanotechnology Journals: Pharmaceutical Nanotechnology, Journal of Pharmaceutics & Drug Delivery Research, Nano Today, International Journal of Pharmaceutical Sciences and Nanotechnology, International Journal of Medicine and Nanotechnology, Journal of Nanopharmaceutics and Drug Delivery and Journal of Nanotechnology

Track 8: Nano particulate Drug Delivery Systems

Nanoparticles (NPs) occur naturally and have been in existence for thousands of years as products of combustion and cooking of food. Nanomaterials differ significantly from other materials due to the following two major principal factors: the increased surface area and quantum effects. These factors can enhance properties such as reactivity, strength, electrical characteristics, and in vivo behavior. As the particle size decreases, a greater proportion of atoms are found at the surface compared to inside. An NP has a much greater surface area per unit mass compared with larger particles, leading to greater reactivity. In tandem with surface area effects, quantum effects can begin to dominate the properties of matter as size is reduced to the nanoscale. These can affect the optical, electrical, and magnetic behavior of materials. Their in vivo behavior can be from increased absorption to high toxicity of nanomaterials. New drug carrier systems are one can name soluble polymers, microparticles made of insoluble (or) biodegradable natural and synthetic polymers, microcapsules, cells, cell ghosts, lipoproteins, liposomes and micelles. Pharmaceutica 2022 evolves to be a drug disintegration conference, emulsion conference, capsule conference, and solubility conference. Pharmaceutical conferences will cover industry case studies, regulatory updates, latest therapies and technology innovations and much more.

Key players in the market include Amgen, Inc., AstraZeneca plc, Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, PolyPeptide Group, and Peptisyntha Inc. at the pharmaceutical companies’ conference

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Novel Drug Delivery Systems Societies in USA: Drug Delivery Foundation, Controlled Release Society, Society for Biomaterials, Academy of Managed Care Pharmacy (AMCP), Accreditation Council for Pharmacy Education, American Association of Colleges of Pharmacy (AACP), American Association of Pharmaceutical Scientists (AAPS), American Association of Pharmacy Technicians (AAPT), American College of Clinical Pharmacy (ACCP)

Novel Drug Delivery Systems Societies in Europe: Austrian Association of Hospital Pharmacists, Austrian Pharmaceutical Society, British Pharmaceutical Nutrition Group, Deutsche Gesellschaft fur Geschichte der Pharmazie, Guild of Healthcare Pharmacists, International Pharmaceutical Federation (FIP), International Pharmaceutical Students' Federation, Royal Microscopial Society, Royal Pharmaceutical Society of Great Britain, Society of Hospital Pharmacists of Australia and Turkish Pharmacists Association

Novel Drug Delivery Systems Societies in Asia and Pacific: Cooperative Research Centres (CRC) Association, Kuwait Pharmaceutical Association, Malaysian Pharmaceutical Society, Pharmaceutical Society of Australia, Pharmaceutical Society of Korea, Pharmacy Guild of Australia and The Pharmaceutical Association of Mauritius

Novel Drug Delivery Systems Journals: Indian Journal of Novel Drug Delivery, Madridge Journal of Novel Drug Research (MJNDR), Journal of Drug Delivery, Journal of Nanopharmaceutics and Drug Delivery, Journal of Drug Delivery Science and Technology, Journal of Controlled Release, International Journal of Drug Delivery, Current Drug Delivery and Drug Delivery and Translational Research

Track 9: Smart Drug Delivery Systems

Smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts of the body where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of a targeted drug delivery systems is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Drug Delivery Societies in USA: Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

Drug Delivery Societies in Europe: Austrian Pharmaceutical Society, Croatian Pharmaceutical Society, Czech Pharmaceutical Society, European Pharmaceutical Students Association, FIGON - Netherlands Federation for Innovative Drug Research, Finnish Pharmaceutical Society, German Pharmaceutical Society (DPhG), Hellenic Pharmaceutical Society and Hungarian Society for Pharmaceutical Sciences (HSPS)

Drug Delivery Societies in Asia and Pacific: Indian Pharmaceutical Association, Indian Drug Manufacturers' Association and Bulk Drug Manufacturers Association India

Drug Delivery Journals: Journal of Drug Delivery, Journal of Pharmaceutics & Drug delivery Research, Journal of Drug Delivery Science and Technology, Advanced Drug Delivery Reviews, Drug Delivery, International Journal of Drug Delivery, Journal of Nanopharmaceutics and Drug Delivery, Drug Delivery and Translational Research, American Journal of Drug Delivery and Therapeutics, American Journal of Drug Delivery, Journal of Advanced Drug Delivery, International Journal of Drug Delivery Technology, Journal of Drug Delivery Research

Track 10: Nanomedicine and Biomedical Applications

Nanomedicine is simply the nanotechnology applications in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behavior of drug substances and in drug delivery. Today, nanomedicine conferences are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced delivery systems, new therapies, and in vivo imaging.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Nanomedicine Societies in USA: American Academy of Nanomedicine, Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nano Medicine, International Association of Nanotechnology and Graphene Stakeholders Association

Nanomedicine Societies in Europe: Nanotechnology Industries Association, Royal Microscopical Society, Royal Society - Nanotechnology and Nanoscience, British Society for Nanomedicine, European Society for Nanomedicine, French Society for Nanomedicine, European NanoBusiness Association, European Society for Precision Engineering and Nanotechnology, Czech Nanotechnology Industries Association and Erwin Schrödinger Society for Nanosciences

Nanomedicine Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Nanomedicine Journals: Nanomedicine: Nanotechnology, Biology and Medicine, Journal of Nanomedicine & Biotherapeutic Discovery, Journal of Nanomedicine & Nanotechnology, Nanomedicine Journal (MJN), International Journal of Nanomedicine, European Journal of Nanomedicine, Nanomedicine and Nanobiotechnology, American Journal of Nanotechnology, Journal of Nanomedicine Research (JNMR), Journal of Nanotechnology , Nanotechnology, Science and Applications and Journal of Nanoparticle Research, Journal of Interdisciplinary Nanomedicine (JOIN)

Track 11: Biomaterials in Drug Delivery

A biomaterial is any substance that has been engineered to interact with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one. Biomaterials conferences can be derived either from nature or synthesized in the laboratory using a variety of chemical approaches utilizing metallic components, polymers, ceramics or composite materials. They are often used and/or adapted for a medical application, and thus comprise whole or part of a living structure or biomedical device which performs, augments, or replaces a natural function. Such functions may be benign, like being used for a heart valve, or may be bioactive with a more interactive functionality such as hydroxy-apatite coated hip implants. Biomaterials 2022 are also used every day in dental applications, surgery, and drug delivery. For example, a construct with impregnated pharmaceutical products can be placed into the body, which permits the prolonged release of a drug over an extended period of time. A biomaterial may also be an autograft, allograft or xenograft used as a transplant material.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Biomaterials Societies in USA: Society for Biomaterials (SFB), The Canadian Biomaterials Society (CBS), American National Standards Institute Nanotechnology Panel (ANSI-NSP), National Nanotechnology Initiative, International Institute for Nanotechnology and Nanoscience and Nanotechnology Center

Biomaterials Societies in Europe: European Society for Biomaterials, Russian Nanotechnology Corporation, NanoNed, Nanotechnology Industries Association (NIA), International Iberian Nanotechnology Laboratory, Swiss Nanoscience Institute (SNI), London Centre for Nanotechnology and Romanian Society for Biomaterials

Biomaterials Societies in Asia and Middle East: International Union of Societies for Biomaterials Science and Engineering (IUSBSE), Chinese Society for Biomaterials (CSBM), Asian Polymer Association (APA), National Center for Nanoscience and Technology, National Institute for Nanotechnology, Australian Institute for Bioengineering and Nanotechnology, Egypt Nanotechnology Center, International Center for Materials Nanoarchitectonics, Korean Society for Biomaterials, Australasian Society for Biomaterials and Tissue Engineering and Society for Biomaterials & Artificial Organs

Biomaterials Journals: Biomaterials, Journal of Biomedical Materials Research, Acta Biomaterialia, Journal of Biotechnology & Biomaterials, International Journal of Biomaterials, Journal of Biomaterials Applications and Biomaterials Science

Track 12: Vaccine Drug Delivery Systems

Vaccine is a material that induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. Sub-unit vaccines though exceptionally selective and specific in reacting with antibodies often fail to show such reactions in circumstances such as shifts in epitopic identification center of antibody and are poorly immunogenic. Delivery of antigens from oil-based adjuvants such as Freunds adjuvant lead to a reduction in the number of doses of vaccine to be administered but due to toxicity concerns like inductions of granulomas at the injection site, such adjuvants are not widely used. FDA approved adjuvants for human uses are aluminium hydroxide and aluminium phosphate in the form of alum. Hence, search for safer and potent adjuvants resulted in the formulations of antigen into delivery systems that administer antigen in particulate form rather than solution form.

Other reasons driving the development of vaccines as controlled drug delivery systems are as follows:

Immunization failure with conventional immunization regimen involving prime doses and booster doses, as patients neglect the latter. Vaccines delivery systems on the other hand:
Allow for the incorporation of doses of antigens so that booster doses are no longer necessary as antigens are released slowly in a controlled manner.
Control the spatial and temporal presentation of antigens to the immune system there by promoting their targeting straight to the immune cells.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Drug Delivery Societies in Asia and Pacific: Indian Pharmaceutical Association, Indian Drug Manufacturers' Association and Bulk Drug Manufacturers Association India

Track 13: Medical Devices for Drug Delivery

In this session we will focus on medical devices designed for drug delivery conferences through the pulmonary and nasal routes. These routes are of interest for local delivery, as in asthma, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that account for specific anatomical and physiological features of the intranasal and pulmonary routes will be featured. Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treatments. Many in the industry have long felt overly burdened by what they consider to be an unnecessarily complex approval process. Critics claim it impedes innovation and delays the availability of better health care. In order to help innovators bring health care to the public Pharmaceutica 2022 hosts drug delivery conferences throughout the year.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Drug Delivery Societies in Asia and Pacific: Indian Pharmaceutical Association, Indian Drug Manufacturers' Association and Bulk Drug Manufacturers Association India

Track 14: Biologics & Biosimilars:

Biologics are medicines made from living cells through highly complex manufacturing processes and must be handled and administered under carefully monitored conditions. Biologics are used to prevent, treat, diagnose, or cure a variety of diseases including cancer, chronic kidney disease, autoimmune disorders, and infectious diseases. Euro Biosimilars is exactly what its name implies — it is a biologic that is “similar” to another biologic drug already approved by the FDA. Under U.S. law, a biosimilar is approved based on a showing that it is “highly similar” to an FDA-approved biological product, known as a reference product. It may not have any clinically meaningful differences in terms of safety and effectiveness from the reference product.

For more information visit: Pharmaceutical Conferences

Related Conferences:

Related Societies:

Track 15: Pharmaceutical Analysis

Pharmaceutical analysis 2022 is a process or a sequence of processes to identify and/or quantify a substance or drug, the components of a pharmaceutical solution or mixture or the determination of the structures of chemical compounds used in the formulations 2022 of pharmaceutical product. Analytical techniques conferences mainly used for the separation of the components from the mixture and for the determination of the structure of the compounds.

For more information visit: Pharmaceutical Conferences

Related Conferences: